SE7612534L - Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning - Google Patents

Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning

Info

Publication number
SE7612534L
SE7612534L SE7612534A SE7612534A SE7612534L SE 7612534 L SE7612534 L SE 7612534L SE 7612534 A SE7612534 A SE 7612534A SE 7612534 A SE7612534 A SE 7612534A SE 7612534 L SE7612534 L SE 7612534L
Authority
SE
Sweden
Prior art keywords
calcium
paget
disease
pharmaceuticals
procedure
Prior art date
Application number
SE7612534A
Other languages
English (en)
Inventor
M Schmidt-Dunker
M Potokar
Original Assignee
Henkel & Cie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752553963 external-priority patent/DE2553963A1/de
Priority claimed from DE19752553962 external-priority patent/DE2553962A1/de
Priority claimed from DE19752553964 external-priority patent/DE2553964A1/de
Application filed by Henkel & Cie Gmbh filed Critical Henkel & Cie Gmbh
Publication of SE7612534L publication Critical patent/SE7612534L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7612534A 1975-12-01 1976-11-10 Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning SE7612534L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19752553963 DE2553963A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DE19752553962 DE2553962A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DE19752553964 DE2553964A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels

Publications (1)

Publication Number Publication Date
SE7612534L true SE7612534L (sv) 1977-06-02

Family

ID=27186643

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612534A SE7612534L (sv) 1975-12-01 1976-11-10 Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning

Country Status (7)

Country Link
US (1) US4086334A (sv)
AT (1) AT347578B (sv)
DK (1) DK506476A (sv)
FR (1) FR2333515A1 (sv)
GB (1) GB1571279A (sv)
NL (1) NL7612673A (sv)
SE (1) SE7612534L (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US5104863A (en) * 1984-12-21 1992-04-14 The Procter & Gamble Company Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
JPS62185092A (ja) * 1986-02-07 1987-08-13 Teijin Ltd 新規ホスホン酸誘導体および除草剤
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
DE3930130A1 (de) * 1989-09-09 1991-03-21 Boehringer Mannheim Gmbh Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
WO1997012619A1 (en) * 1995-09-29 1997-04-10 Novartis Ag Method of treating the navicular disease in horses
US5753633A (en) * 1997-04-11 1998-05-19 Colgate-Palmolive Company Method of inhibiting bone resorption
PL360910A1 (en) * 2000-09-18 2004-09-20 F H Faulding & Co Limited Diphosphonate solutions
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
BRPI0410805A (pt) * 2003-09-09 2006-06-27 Fumapharm Ag uso de derivados do ácido fumárico para tratamento da insuficiência cardìaca e asma

Also Published As

Publication number Publication date
NL7612673A (nl) 1977-06-03
DK506476A (da) 1977-06-02
US4086334A (en) 1978-04-25
GB1571279A (en) 1980-07-09
FR2333515B1 (sv) 1980-03-07
ATA885676A (de) 1978-05-15
FR2333515A1 (fr) 1977-07-01
AT347578B (de) 1979-01-10

Similar Documents

Publication Publication Date Title
SE7612534L (sv) Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
RU92004521A (ru) Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
EP0751769A4 (en) MEDICAL TREATMENT USING THYROID HORMONES
FI893783A (sv) Förfarande för framställning av ett farmaceutiskt preparat för vård av diabetes mellitus
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
ATE181505T1 (de) Phosphozucker enthaltende pharmazeutische zubereitung
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
KR910005858A (ko) 지방산 요법
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
HU9401656D0 (en) Pharmaceutical composition for treating tumours, containing creatine phosphate or phospho-enol-pyruvic acid
IL101675A (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
KR927002224A (ko) 항종양효과증강제 및 항종양제
JPS5630917A (en) Preventive and remedy for hepatitis
KR900701278A (ko) 바이러스 감염 치료용 담즙산
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ATE195868T1 (de) Pharmazeutische zusammensetzungen von gallium- komplexen von 3-hydroxy-4-pyronen
ES2072270T3 (es) Agente farmaceutico administrable por via oral, especialmente para la terapia de substitucion de hierro y de magnesio.
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
FR2449449A2 (fr) Composes indoliques nouveaux utiles comme medicaments

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612534-3

Format of ref document f/p: F